Your session is about to expire
← Back to Search
Educational Video for Patient Empowerment
N/A
Recruiting
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients will be ASA 1-3 undergoing elective surgery
Patients must be adults (> 18 years of age) undergoing knee or hip arthroplasty
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours post operatively
Awards & highlights
Study Summary
This trial will test whether an online educational video presentation can help patients use opioids safely and reduce the overall amount of opioids used after surgery.
Who is the study for?
Adults over 18 scheduled for knee or hip replacement surgery can join this trial. They must understand English, have internet access, and score at least 18 on a cognitive test. People with severe liver issues, allergies to local anesthesia, chronic pain conditions, opioid use before the study, certain psychiatric disorders or vision loss cannot participate.Check my eligibility
What is being tested?
The trial is testing if watching a pre-operative educational video about using opioids safely and other pain management techniques can reduce opioid consumption after surgery. The video includes instructions on medication use and exercises to cope with pain.See study design
What are the potential side effects?
Since the intervention is an educational video rather than a medical treatment or drug, there are no direct side effects associated with it. However, improper application of the learned techniques could potentially lead to inadequate pain control.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am healthy or have mild to severe systemic disease and am scheduled for elective surgery.
Select...
I am an adult having knee or hip surgery.
Select...
I scored at least 18 on the MoCA test, showing I can understand instructions for pain management.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 hours post operatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours post operatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Post operative opioid consumption
Secondary outcome measures
Postoperative Pain
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Opioid Counseling and PCS Video GroupExperimental Treatment1 Intervention
This arm of the study will receive the opioid counseling and pain coping skills video 2 weeks prior to their surgery in addition to the conventional information provided to all patients undergoing total joint arthroplasty.
Group II: Standard of Care GroupActive Control1 Intervention
This arm of the study will the conventional information provided to all patients undergoing total joint arthroplasty.
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,088 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am on dialysis.I am healthy or have mild to severe systemic disease and am scheduled for elective surgery.I have severe liver problems.I am an adult having knee or hip surgery.I refuse to consent to spinal or nerve block anesthesia.I need emergency surgery for a fracture.My heart or lung condition is in its final stage.I scored at least 18 on the MoCA test, showing I can understand instructions for pain management.I regularly use opioids for pain management.I have significant difficulties with my memory or thinking.I experience nerve pain.I have been on long-term opioid medication for chronic pain.I am receiving treatment for a psychological condition.I am experiencing vision loss.
Research Study Groups:
This trial has the following groups:- Group 1: Opioid Counseling and PCS Video Group
- Group 2: Standard of Care Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for individuals to partake in this experiment currently?
"Affirmative. According to information on clinicaltrials.gov, this medical trial is actively looking for participants as of September 27th 2022. The study was first posted on the 20th and aims to enroll 220 people at one site."
Answered by AI
How many people have been included in the data gathering for this trial?
"Affirmative. Clinicaltrials.gov records show that this investigation, which was published on the 20th of September 2022, is actively recruiting participants. Approximately 220 people need to be signed up from a single medical centre."
Answered by AI
Share this study with friends
Copy Link
Messenger